ONCOLYTICS BIOTECH INC Logo

ONCOLYTICS BIOTECH INC

Clinical-stage biopharma developing an intravenously delivered immuno-oncolytic virus.

ONCY | US

Overview

Corporate Details

ISIN(s):
CA6823108759
LEI:
Country:
United States of America
Address:
804, 322 - 11 AVENUE SW, CALGARY

Description

Oncolytics Biotech Inc. is a clinical-stage biopharmaceutical company developing pelareorep, an intravenously delivered immuno-oncolytic virus. This immunotherapeutic agent is designed to selectively replicate in cancer cells, which triggers innate and adaptive anti-tumor immune responses. By awakening the patient's immune system, pelareorep aims to enhance the efficacy of other oncology treatments, such as chemotherapy and immune checkpoint inhibitors. The company's clinical development program is evaluating its potential across various cancer types, with a focus on HR+/HER2- breast cancer and pancreatic cancer, where it has demonstrated the potential to extend survival times and reduce tumor burden.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-16 15:03
6-K
English 16.7 KB
2025-12-10 06:15 English 5.0 KB
2025-12-10 00:02
6-K
English 17.0 KB
2025-12-09 23:26
424B3
English 1.7 MB
2025-12-05 23:05
F-4/A
English 2.4 MB
2025-11-20 22:06
6-K
English 13.1 KB
2025-11-19 15:02
6-K
English 15.2 KB
2025-11-14 21:05 English 10.8 KB
2025-11-12 23:28
6-K
English 720.4 KB
2025-11-04 14:11
6-K
English 15.3 KB
2025-10-28 12:43
6-K
English 16.7 KB
2025-10-20 15:02
6-K
English 16.5 KB
2025-10-18 03:54
FORM 6-K
English 120.8 KB
2025-10-18 03:52
F-4
English 1.7 MB
2025-10-17 22:20
424B5
English 128.9 KB

Automate Your Workflow. Get a real-time feed of all ONCOLYTICS BIOTECH INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ONCOLYTICS BIOTECH INC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ONCOLYTICS BIOTECH INC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.